These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 26376814
1. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients. Yalçın S, Mutlu P, Çetin T, Sarper M, Özgür G, Avcu F. Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814 [Abstract] [Full Text] [Related]
2. Association of -174G/C interleukin/6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients. Mutlu P, Yalcin S, Elci P, Yildirim M, Cetin AT, Avcu F. J BUON; 2014 Dec; 19(3):787-91. PubMed ID: 25261668 [Abstract] [Full Text] [Related]
6. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population]. Zhang PA, Wu JM, Li Y, Yang XS. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941 [Abstract] [Full Text] [Related]
7. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL. Dong HJ, Fang C, Fan L, Zhu DX, Wang DM, Zhu HY, Zhuang Y, Miao KR, Liu P, Xu W, Li JY. Int J Cancer; 2012 May 01; 130(9):2054-61. PubMed ID: 21647873 [Abstract] [Full Text] [Related]
11. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients. Annuar AA, Ankathil R, Mohd Yunus N, Husin A, Ab Rajab NS, Abdul Aziz AA, Ibrahim MI, Sulong S. Asian Pac J Cancer Prev; 2021 Feb 01; 22(2):565-571. PubMed ID: 33639675 [Abstract] [Full Text] [Related]
14. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia. Karabon L, Partyka A, Jasek M, Lech-Maranda E, Grzybowska-Izydorczyk O, Bojarska-Junak A, Pawlak-Adamska E, Tomkiewicz A, Robak T, Rolinski J, Frydecka I. Arch Immunol Ther Exp (Warsz); 2016 Dec 01; 64(Suppl 1):137-145. PubMed ID: 27933341 [Abstract] [Full Text] [Related]
15. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population. Suwalska K, Pawlak E, Karabon L, Tomkiewicz A, Dobosz T, Urbaniak-Kujda D, Kuliczkowski K, Wolowiec D, Jedynak A, Frydecka I. Hum Immunol; 2008 Mar 01; 69(3):193-201. PubMed ID: 18396212 [Abstract] [Full Text] [Related]
16. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia. Edathara PM, Gorre M, Kagita S, Vuree S, Cingeetham A, Nanchari SR, Meka PB, Annamaneni S, Digumarthi RR, Satti V. Tumour Biol; 2016 Apr 01; 37(4):5475-84. PubMed ID: 26563376 [Abstract] [Full Text] [Related]
17. Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis. Zhou Y, Yamaguchi E, Hizawa N, Nishimura M. Sarcoidosis Vasc Diffuse Lung Dis; 2005 Jun 01; 22(2):105-13. PubMed ID: 16053025 [Abstract] [Full Text] [Related]
18. Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, Ansaripour B, Moradi B, Nikbin B. Int J Immunogenet; 2005 Jun 01; 32(3):167-71. PubMed ID: 15932621 [Abstract] [Full Text] [Related]
19. [Association of CD38 gene polymorphism with pathogenesis of chronic myeloid leukemia]. Li J, Zhu JF, Zhang W, Ma HZ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr 01; 19(2):284-7. PubMed ID: 21518472 [Abstract] [Full Text] [Related]
20. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population. Mohammed Basabaeen AA, Abdelgader EA, Babekir EA, Abdelrahim SO, Eltayeb NH, Altayeb OA, Fadul EA, Sabo A, Ibrahim IK. Asian Pac J Cancer Prev; 2019 May 25; 20(5):1579-1585. PubMed ID: 31128065 [Abstract] [Full Text] [Related] Page: [Next] [New Search]